Statins × glycemic control

TrialBMC medical genomics2019

Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients.

Daniel Margerie et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 2019

Not counted

Probably raised glycemic control

2.7×1.6× to 4.5×

Bigger than 7 in 10 for glycemic control

As reported

OR 2.67, 95% CI 1.60–4.45

One number in the abstract

the abstract, start to end

showed higher diabetes prevalence (OR = 2.67; 95%CI, 1.60-4.45; P = 0.0002)

← favours treatmentfavours comparator →
could be chance
Glycemic control
OR 2.671.60–4.45
StatinsGlycemic control
1 / 3

21 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31159817